Steven J. Rice - 25 Jun 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Chief Administrative Officer
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 25 Jun 2021
Net transactions value: -$112
Form type: 4
Filing time: 29 Jun 2021, 17:12:23 UTC
Next filing: 24 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$38.28	+3	+0.02%	$12.76	20,003	25 Jun 2021	Direct
transaction	VIR	Common Stock	Sale	$150	-3	-0.01%	$50.00	20,000	25 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Employee Stock Option (Right to Buy)	Options Exercise	$0	-3	-0%	$0.000000	444,441	25 Jun 2021	Common Stock	3	$12.76	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
F2	1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.